We found that high GPC1 expression was associated with advanced T stage (Figure 2(a), T1&T2 = 94, T3&T4 = 383; p = 0.038), N stage (Figure 2(b), N0 = 284, N1&N2 = 194, p < 0.001), M stage (Figure 2(c), M0 = 349; M1 = 66; p = 0.04), and pathologic stage (Figure 2(d), Stage I and Stage II = 268, Stage III and Stage IV = 199, p < 0.001), indicating that patients with more advanced tumor stage or higher grade tumors were more likely to have higher levels of GPC1. The gene discussed is GPC1; the disease is neoplasm.